Prof. Stephen Pennington showcases psoriasis and psoriatic arthritis research in India

Conway Fellow, Professor Stephen Pennington, UCD School of Medicine recently presented the work of IMI HIPPOCRATES on psoriasis and psoriatic arthritis at multiple high-profile events in India.

Prof. Pennington introduced the project’s groundbreaking research on protein biomarkers and their role in advancing precision medicine for psoriatic disease.

During his tour, Prof. Pennington engaged with diverse audiences, from school students and the general public to academic researchers and industry professionals. His presentations highlighted the importance of biomarker discovery and development in improving patient outcomes and shaping the future of healthcare.

Prof. Pennington’s participation in these events underscored HIPPOCRATES’ commitment to global collaboration and knowledge exchange in the field of precision medicine. His talks sparked discussions on the role of protein biomarkers in disease management, fostering potential research and industry partnerships.

The HIPPOCRATES project continues to drive innovation in the study of psoriatic disease, aiming to translate biomarker research into clinical applications that enhance patient care worldwide.

Highlights from the Roadshow

MOOD-OMICS, IIT Bombay (February 15, 2025)
'From Skin to Bones'
Accessible talk on protein biomarkers for clinical use in psoriasis, delivered to over 1,000 attendees, including schoolchildren, the general public, and conference participants. 

APT-2025 Conference, VMCC, Mumbai (February 16, 2025)
International Symposium at Banaras Hindu University (BHU), Varanasi (February 18, 2025)
'Discovery and Development of Biomarkers for Psoriatic Disease'

International Symposium on Biology & Medicine in AI Era, SRHU, Dehradun (February 20, 2025)
"From Protein Biomarker Discovery to Clinical Utility in Psoriatic Disease"

Symposium at Apeejay School of Management (ASM), Dwarka Delhi (February 21, 2025)
"Protein Biomarkers to Improve Patient Outcomes: From Bench to Business"